Cancer Innovation (Dec 2023)

Hepatoblastoma with neonatal necrotizing enterocolitis: Two case reports

  • Sidou He,
  • Xisi Wang,
  • Chao Duan,
  • Wen Zhao,
  • Chiyi Jiang,
  • Shihan Zhang,
  • Binglin Jian,
  • Wei Yang,
  • Tong Yu,
  • Libing Fu,
  • Huanmin Wang,
  • Xiaoli Ma

DOI
https://doi.org/10.1002/cai2.86
Journal volume & issue
Vol. 2, no. 6
pp. 532 – 536

Abstract

Read online

Abstract We report two children with hepatoblastoma (HB) with a history of neonatal necrotizing enterocolitis (NEC). Case 1 was diagnosed with HB at 5 months of age. Liver enlargement was found during the NEC operation at 3 months of age and then was clinically diagnosed by imaging. After six chemotherapy courses, a partial hepatectomy was performed. Three months after ceasing the chemotherapy, a chest computed tomography scan suggested that distant metastasis of the tumor should be considered, and the lesion was removed. However, 9 months after the operation, alpha‐fetoprotein concentrations were increased, and abdominal imaging showed a recurrence of the tumor in situ, resulting in a hepatectomy. Case 2 was diagnosed with NEC shortly after birth and underwent an intestinal resection and anastomosis 1 month later. He was diagnosed with HB at 3 years of age. Hepatectomy was performed after five courses of chemotherapy. Chemotherapy was stopped after 10 courses, and alpha‐fetoprotein concentrations were normal. At present, both children have survived and are in a healthy condition. Physicians should be aware of the possibility of HB and a history of NEC in children. Premature birth and low birth weight are common factors leading to the pathogenesis of HB and NEC. The association between these two diseases requires further study.

Keywords